Cytosorbents CorporationCTSONASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank27
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-18.18M
Near historical average
Percentile
P27
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-17.74M
Historical baseline
PeriodValueYoY Change
TTM$-18.18M-19.5%
2024$-15.22M+45.4%
2023$-27.88M+7.1%
2022$-30.00M-38.8%
2021$-21.62M-122.6%
2020$-9.71M+48.2%
2019$-18.74M-17.3%
2018$-15.98M-95.6%
2017$-8.17M+31.1%
2016$-11.86M-